Active Ingredient History

  • Now
Alteplase (t-PA), a biosynthetic form of human tissue-type plasminogen activator (t-PA), is a thrombolytic medication, used to treat acute ischemic stroke, acute ST-elevation myocardial infarction, pulmonary embolism associated with low blood pressure, and blocked central venous catheter. It is given by injection into a vein or artery. Alteplase is the same as the normal human plasminogen activator produced in vascular endothelial cells and is synthesized via recombinant DNA technology in Chinese hamster ovary cells (CHO). Alteplase causes the breakdown of a clot by inducing fibrinolysis.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$113.2200 - $150.7530
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

actilyse | actilyse cathflo | activase | altelplase | alteplase | alteplase (genetical recombination) | alteplase,recombinant | alteplase, recombinant | cathflo activase | human tissue plasminogen activator | plasminogen activator (human tissue-type protein moiety) | prourokinase | recombinant human plasminogen activator | recombinant human prourokinase | rh-prouk | rt-pa | thrombolysin | tissue plasminogen activator | tissue-plasminogen activator | tissue plasminogen activator alteplase | tissue plasminogen activator, recombinant | tnkase | tpa | t-pa | t-plasminogen activator


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue